Autolus Therapeutics (AUTL) Tax Provisions (2017 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Tax Provisions of -$1.2 million for Q4 2025, down 179.0% year-on-year from $1.5 million in Q4 2024, and down 317.11% on a QoQ basis from $532000.0 in Q3 2025.
Autolus Therapeutics (AUTL) Tax Provisions (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Tax Provisions for 9 consecutive years, with -$1.2 million the latest figure, recorded in Q4 2025.
- Quarterly Tax Provisions fell 179.0% year-over-year to -$1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (up 30.91% YoY) and the FY2025 annual result came in at $2.0 million, up 30.89% from the prior year.
- Tax Provisions fell to -$1.2 million in Q4 2025 per AUTL's latest filing, from $532000.0 in the prior quarter.
- Over the last five years, Tax Provisions for AUTL reached as high as $19.6 million in Q4 2022 and fell as low as -$6.4 million in Q2 2021.
- A 5-year average of $1.2 million and a median of -$6500.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions tumbled 320.0% — and 2025, when it soared 27912.5%.
- Year by year, Tax Provisions stood at $17.6 million in 2021, then advanced by 11.29% to $19.6 million in 2022, then sank by 100.12% to -$24000.0 in 2023, then surged by 6191.67% to $1.5 million in 2024, then slumped by 179.0% to -$1.2 million in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered -$1.2 million, $532000.0, and $397000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | -1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.16 Mn |
| Sep 30, 2025 | 532,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | -8,000.00 |
| Dec 31, 2023 | -24,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | 19.55 Mn |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -56,000.00 |
| Mar 31, 2022 | -26,000.00 |
| Dec 31, 2021 | 17.57 Mn |
| Sep 30, 2021 | -5.39 Mn |
| Jun 30, 2021 | -6.36 Mn |
| Mar 31, 2021 | -5.72 Mn |